Exploring Psychiatrist Opinions and Expectations Around the Rise in Digital Therapeutics to Treat Mental Health
The National Institutes of Health (NIH) believe “technology has opened a new frontier in mental health support,” but questions remain around how psychiatrists feel about these shifts in care delivery, especially with digital therapeutics (DTx)—defined as treatments delivered directly to patients via software or apps. DTx overall have a relatively small presence today, only about $5 billion globally, but are expected to be a $56 billion market in ten years.
In this report InCrowd set out to:
- Explore the adoption experience and examine the non-adopter’s usage hesitancy
- Better understand how the adoption experience influences future forecasts
- Assess how adopters and non-adopters can best be supported going forward
Get our latest Instant Insights report to see the results.